Back To Top

Tangs Clinic

  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Categories
    Categories Displays a list of categories from this blog.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
  • Archives
    Archives Contains a list of blog posts that were created previously.
  • Login
    Login Login form
07
Oct

Biologic Therapy and Risk of Infection

Posted by on in Skin Matters
  • Font size: Larger Smaller
  • Hits: 11034
  • 0 Comments
  • Print

Biologic compounds are being used more frequently to treat a multitude of systemic inflammatory conditions. These novel compounds are composed of antibodies or other peptides that act through one of three mechanisms: inhibiting inflammatory cytokine signaling (typically tumor necrosis factor or TNF), inhibiting T-cell activation, or depleting B-cells. The increase in use and ever expanding list of new immune modulating therapies make knowledge of the infectious complications associated with immune modulation even more important. Of particular concern is the risk for developing atypical and opportunistic infections including tuberculosis, herpes zoster, Legionella pneumophila, and Listeria monocytogenes.

Biologic Therapy and Risk of Infection

Reference:
Rachel Gordon, Rana Mays, Hung Doan, Whitney Lapolla, Stephen K. Tyring. (2012). Biologic Therapy and Risk of Infection. Skin therapy Letter. Volume 17, Number 4, Aprial 2012.

Rate this blog entry:

Comments

  • No comments made yet. Be the first to submit a comment

Leave your comment

Guest Monday, 28 May 2018